Related references
Note: Only part of the references are listed.Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study
Tiago Nunes da Silva et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)
Translating the immune microenvironment of thyroid cancer into clinical practice
Lucas Leite Cunha et al.
ENDOCRINE-RELATED CANCER (2022)
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson et al.
CANCER RESEARCH (2021)
Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans
Grigorios Panagiotou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics
Ichiro Abe et al.
CURRENT ONCOLOGY REPORTS (2021)
Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism
Cinthia Carolina Stempin et al.
CANCERS (2021)
Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer
Ines J. Marques et al.
THYROID (2021)
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force
Keith C. Bible et al.
THYROID (2021)
Immune Landscape of Thyroid Cancers: New Insights
Elisa Menicali et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
You-Take Oh et al.
BIOMOLECULES (2021)
M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway
Juan Lv et al.
MOLECULAR MEDICINE REPORTS (2021)
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases
Bin Xu et al.
THYROID (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function
Ahmed El Motiam et al.
FASEB JOURNAL (2019)
The role of EIF1AX in thyroid cancer tumourigenesis and progression
J. Simoes-Pereira et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies
Inigo Landa et al.
CLINICAL CANCER RESEARCH (2019)
Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options
Joana Simoes-Pereira et al.
CANCERS (2019)
The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines
S. Lopes-Ventura et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers
Jae Won Cho et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology
Ana T. Pinto et al.
ENDOCRINE (2019)
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev et al.
CLINICAL CANCER RESEARCH (2018)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours
Mrinal K. Das et al.
SCIENTIFIC REPORTS (2018)
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Naiyarat Prasongsook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells
Wai-Kin So et al.
TUMOR BIOLOGY (2016)
New insights into functional regulation in MS-based drug profiling
Ana Sofia Carvalho et al.
SCIENTIFIC REPORTS (2016)
Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells
Yi Rang Na et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
The developing story of Sprouty and cancer
Samar Masoumi-Moghaddam et al.
CANCER AND METASTASIS REVIEWS (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
Jaime Miguel Pita et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Global Mass Spectrometry and Transcriptomics Array Based Drug Profiling Provides Novel Insight into Glucosamine Induced Endoplasmic Reticulum Stress
Ana Sofia Carvalho et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration
Trevor E. Angell et al.
THYROID (2014)
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Moira Ragazzi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and Polarization: Lessons and Open Questions
Alberto Mantovani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
Mabel Ryder et al.
PLOS ONE (2013)
SIR: Deterministic protein inference from peptides assigned to MS data
Rune Matthiesen et al.
JOURNAL OF PROTEOMICS (2012)
mRNA Expression in Papillary and Anaplastic Thyroid Carcinoma: Molecular Anatomy of a Killing Switch
Aline Hebrant et al.
PLOS ONE (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
Tumour macrophages as potential targets of bisphosphonates
Thea L. Rogers et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
Bernard Caillou et al.
PLOS ONE (2011)
Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPAR(Y) in Non-Small Cell Lung Cancer
Meredith A. Tennis et al.
MOLECULAR CANCER RESEARCH (2010)
Universal sample preparation method for proteome analysis
Jacek R. Wisniewski et al.
NATURE METHODS (2009)
Sprouty proteins, masterminds of receptor tyrosine kinase signaling
Miguel A. Cabrita et al.
ANGIOGENESIS (2008)
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
Mabel Ryder et al.
ENDOCRINE-RELATED CANCER (2008)
Anaplastic thyroid cancer
Ryan L. Neff et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
Rebecca E. Schweppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Share Paper
